Polymicrobial interactions: Impact on pathogenesis and human disease

Clinical Microbiology Reviews

Volumn 25, Issue 1, 2012, Pages 193-213

  Peters, Brian M ^a,b   Jabra Rizk, Mary Ann ^a,b   O'May, Graeme A ^b   William Costerton, J ^c   Shirtliff, Mark E ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA VACCINE; PERTUSSIS TOXIN; PNEUMOCOCCUS VACCINE; POLYMICROBIAL VACCINE; RNA 16S; SYNBIOTIC AGENT; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VACCINE; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BACTERIAL SUPERINFECTION; BACTERIOPHAGE; BACTERIUM CULTURE; BIOFILM; BURKHOLDERIA CEPACIA INFECTION; CANDIDA ALBICANS; CLINICAL FEATURE; COAGGREGATION; CYSTIC FIBROSIS; DEBRIDEMENT; DENATURING GRADIENT GEL ELECTROPHORESIS; DENTAL CARIES; DEVICE INFECTION; DIABETIC FOOT; EXTRACELLULAR MATRIX; FUSOBACTERIA; HOST PATHOGEN INTERACTION; HUMAN; HYPERBARIC OXYGEN; IMMUNOCOMPROMISED PATIENT; INTESTINE FLORA; LUNG INFECTION; MAGGOT DEBRIDEMENT THERAPY; MICROBIAL ADHESION; MICROBIAL COLONIZATION; MICROBIAL GROWTH; MICROBIAL IDENTIFICATION; MICROBIAL POPULATION DYNAMICS; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MOUTH CAVITY; MYCOSIS; NONHUMAN; ORGANISMAL INTERACTION; OTITIS MEDIA; PARENTERAL NUTRITION; PATHOGENESIS; PERIODONTITIS; PHAGE THERAPY; PHENOTYPIC VARIATION; REVIEW; SEQUENCE ANALYSIS; STOMACH PH; STOMATITIS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS; THERAPY; TOOTH DISEASE; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VACUUM ASSISTED CLOSURE; VIRUS INFECTION; WOUND INFECTION;

BACTERIA; CATHETER-RELATED INFECTIONS; COINFECTION; CYSTIC FIBROSIS; DIABETIC FOOT; FUNGI; HUMANS; MICROBIAL INTERACTIONS; OTITIS MEDIA; STOMATITIS;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 84855656898     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00013-11     Document Type: Review

References (227)

1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-5732.
2. Abramson JS, Wheeler JG. 1994. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr. Infect. Dis. J. 13:643-652.
3. Alberti KG, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of aWHOconsultation. Diabet. Med. 15:539-553.
4. Al-Fattani MA, Douglas LJ. 2006. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55:999-1008.
5. Andreasen C, Carbonetti NH. 2008. Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect. Immun. 76:5139-5148.
6. Arif N, Sheehy EC, Do T, Beighton D. 2008. Diversity of Veillonella spp. from sound and carious sites in children. J. Dent. Res. 87:278-282.
7. Armbruster CE, et al. 2010. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio 1(3):e00102-10. doi:10.1128/ mBio.00102-10.
8. Armitage GC, Cullinan MP. 2010. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol. 2000 53:12-27.
9. Armstrong DG, Lavery LA. 2005. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366:1704-1710.
10. Armstrong DG, Lavery LA, Boulton AJ. 2007. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity? Int. Wound J. 4:79-86.
11. Azeredo J, Sutherland IW. 2008. The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 9:261-266.
12. Baena-Monroy T, et al. 2005. Candida albicans, Staphylococcus aureus and Streptococcus mutans colonization in patients wearing dental prosthesis. Med. Oral Patol. Oral Cir. Bucal 10(Suppl. 1):E27-E39.
13. Bakaletz LO. 2009. Immunopathogenesis of polymicrobial otitis media. J. Leukoc. Biol. 87:213-222.
14. Bakaletz LO. 1995. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol. 3:110-114.
15. Bamford CV, et al. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 77:3696-3704.
16. Barnes RC. 2006. Hyperbaric oxygen is beneficial for diabetic foot wounds. Clin. Infect. Dis. 43:188-192.
17. Bauer TT, et al. 2002. Biofilm formation in endotracheal tubes. Association between pneumonia and the persistence of pathogens. Monaldi Arch. Chest Dis. 57:84-87.
18. Becker MR, et al. 2002. Molecular analysis of bacterial species associated with childhood caries. J. Clin. Microbiol. 40:1001-1009.
19. Bedrossian CW, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS. 1976. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum. Pathol. 7:195-204.
20. Bogaert D, et al. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871-1872.
21. Boulton, A. J. 2010. What you can't feel can hurt you. J. Vasc. Surg. 52:28S-30S.
22. Bowling FL, Jude EB, Boulton AJ. 2009. MRSA and diabetic foot wounds: contaminating or infecting organisms? Curr. Diab. Rep. 9:440-444.
23. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. 2006. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect. Immun. 74:3415-3426.
24. Brand A, Barnes JD, Mackenzie KS, Odds FC, Gow NA. 2008. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 287:48-55.
25. Brogden KA, Guthmiller JM. 2002. Polymicrobial diseases. ASM Press, Washington, DC.
26. Brogden KA, Guthmiller JM, Taylor CE. 2005. Human polymicrobial infections. Lancet 365:253-255.
27. Cabre E, Gassull MA. 1993. Complications of enteral feeding. Nutrition 9:1-9.
28. Campos MS, Marchini L, Bernardes LA, Paulino LC, Nobrega FG. 2008. Biofilm microbial communities of denture stomatitis. Oral Microbiol. Immunol. 23:419-424.
29. Carlson E. 1983. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect. Immun. 42:285-292.
30. Carlson E. 1982. Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect. Immun. 38:921-924.
31. Carr CS, Ling KD, Boulos P, Singer M. 1996. Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection. BMJ 312:869-871.
32. Carson JL, Collier AM, Hu SS. 1985. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N. Engl. J. Med. 312:463-468.
33. Casanova M, Cervera AM, Gozalbo D, Martinez JP. 1997. Hemin induces germ tube formation in Candida albicans. Infect. Immun. 65: 4360-4364.
34. Castanie-Cornet MP, Penfound TA, Smith D, Elliott JF, Foster JW. 1999. Control of acid resistance in Escherichia coli. J. Bacteriol. 181: 3525-3535.
35. Cazander G, Pawiroredjo JS, Vandenbroucke-Grauls CM, Schreurs MW, Jukema GN. 2010. Synergism between maggot excretions and antibiotics. Wound Repair Regen. 18:637-642.
36. Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CM, Schreurs MW, Jukema GN. 2010. Maggot excretions inhibit biofilm formation on biomaterials. Clin. Orthop. Relat. Res. 468:2789-2796.
37. Cerca N, Oliveira R, Azeredo J. 2007. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett. Appl. Microbiol. 45:313-317.
38. Chonmaitree T, Owen MJ, Howie VM. 1990. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J. Infect. Dis. 162:546-549.
39. Chotirmall SH, et al. 2010. Sputum Candida albicans presages FEV1 decline and hospital-treated exacerbations in cystic fibrosis. Chest 138: 1186-1195.
40. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. 2007. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J. Clin. Microbiol. 45:2819-2828.
41. Costerton JW, Geesey GG, Cheng KJ. 1978. How bacteria stick. Sci. Am. 238:86-95.
42. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
43. Cripps AW, Otczyk DC. 2006. Prospects for a vaccine against otitis media. Expert Rev. Vaccines 5:517-534.
44. Cugini C, et al. 2007. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 65:896-906.
45. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8:481-490.
46. Reference deleted.
47. Dautle MP, Ulrich RL, Hughes TA. 2002. Typing and subtyping of 83 clinical isolates purified from surgically implanted silicone feeding tubes by random amplified polymorphic DNA amplification. J. Clin. Microbiol. 40:414-421.
48. Davies JC, Alton EW, Bush A. 2007. Cystic fibrosis. BMJ 335: 1255-1259.
49. de Carvalho FG, Silva DS, Hebling J, Spolidorio LC, Spolidorio DM. 2006. Presence of mutans streptococci and Candida spp. in dental plaque/dentine of carious teeth and early childhood caries. Arch. Oral Biol. 51:1024-1028.
50. De Soyza A, et al. 2001. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358:1780-1781.
51. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280.
52. de Vrankrijker AM, et al. 2009. Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice. J. Med. Virol. 81:2096-2103.
53. Diaz PI, et al. 2006. Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl. Environ. Microbiol. 72:2837-2848.
54. Diebel LN, Liberati DM, Diglio CA, Dulchavsky SA, Brown WJ. 1999. Synergistic effects of Candida and Escherichia coli on gut barrier function. J. Trauma 47:1045-1050.
55. Dodge JA, Turck D. 2006. Cystic fibrosis: nutritional consequences and management. Best Pract. Res. Clin. Gastroenterol. 20:531-546.
56. Donlan RM. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66-72.
57. Duan K, Dammel C, Stein J, Rabin H, Surette MG. 2003. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol. Microbiol. 50:1477-1491.
58. Dykes GA, Sampathkumar B, Korber DR. 2003. Planktonic or biofilm growth affects survival, hydrophobicity and protein expression patterns of a pathogenic Campylobacter jejuni strain. Int. J. Food Microbiol. 89: 1-10.
59. Emingil G, Atilla G, Huseyinov A. 2004. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J. Clin. Periodontol. 31: 829-834.
60. Falanga V. 2005. Wound healing and its impairment in the diabetic foot. Lancet 366:1736-1743.
61. Falkow S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2):S274-S276.
62. Farag YMK, Gaballa MR. 2 November 2010, posting date. Diabesity: an overview of a rising epidemic. Nephrol. Dial. Transplant. [Epub ahead of print.] doi:10.1093/ndt/gfq576.
63. Freid VM, Makuc DM, Rooks RN. 1998. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat. 13: 1-23.
64. Fu W, et al. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54:397-404.
65. Furrie E, et al. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54:242-249.
66. Galiano RD, et al. 2004. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol. 164:1935-1947.
67. Galkowska H, Wojewodzka U, Olszewski WL. 2006. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 14:558-565.
68. Gardner SE, Frantz RA. 2008. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol. Res. Nurs. 10:44-53.
69. Genco R, et al. 1996. Periodontal diseases: pathogenesis and microbial factors. Ann. Periodontol. 1:926-932.
70. Giebink GS, Ripley ML, Wright PF. 1987. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann. Otol. Rhinol. Laryngol. 96:199-206.
71. Glonti T, Chanishvili N, Taylor PW. 2010. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J. Appl. Microbiol. 108: 695-702.
72. Gonzales R, Malone DC, Maselli JH, Sande MA. 2001. Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis. 33:757-762.
73. Gottlieb K, DeMeo M, Borton P, Mobarhan S. 1992. Gastrostomy tube deterioration and fungal colonization. Am. J. Gastroenterol. 87:1683.
74. Gottlieb K, Iber FL, Livak A, Leya J, Mobarhan S. 1994. Oral Candida colonizes the stomach and gastrostomy feeding tubes. JPEN J. Parenter. Enteral Nutr. 18:264-267.
75. Gottlieb K, Leya J, Kruss DM, Mobarhan S, Iber FL. 1993. Intraluminal fungal colonization of gastrostomy tubes. Gastrointest. Endosc. 39: 413-415.
76. Grimaudo NJ, Nesbitt WE. 1997. Coaggregation of Candida albicans with oral Fusobacterium species. Oral Microbiol. Immunol. 12:168-173.
77. Grimaudo NJ, Nesbitt WE, Clark WB. 1996. Coaggregation of Candida albicans with oral Actinomyces species. Oral Microbiol. Immunol. 11: 59-61.
78. Gursoy S, et al. 2007. Clostridium difficile infection frequency in patientswith nosocomial infections or using antibiotics. Hepatogastroenterology 54:1720-1724.
79. Gustafsson BE. 1982. The physiological importance of the colonic microflora. Scand. J. Gastroenterol. Suppl. 77:117-131.
80. Hagan EC, Mobley HL. 2007. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75:3941-3949.
81. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. 1994. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect. Immun. 62:2707-2714.
82. Hament JM, Kimpen JL, Fleer A, Wolfs TF. 1999. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26:189-195.
83. Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53:3914-3922.
84. Harrison F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology 153:917-923.
85. Hart TC. 1994. Genetic considerations of risk in human periodontal disease. Curr. Opin. Periodontol. 1994:3-11.
86. Haubek D, Ennibi OK, Poulsen K, Benzarti N, Baelum V. 2004. The highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans and progression of periodontal attachment loss. J. Dent. Res. 83:767-770.
87. He XS, Shi WY. 2009. Oral microbiology: past, present and future. Int. J. Oral Sci. 1:47-58.
88. Hoffman LR, et al. 2006. Selection for Staphylococcus aureus smallcolony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 103:19890-19895.
89. Hogan DA, Kolter R. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229-2232.
90. Hogan DA, Vik A, Kolter R. 2004. A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology. Mol. Microbiol. 54:1212-1223.
91. Holmes AR, Gopal PK, Jenkinson HF. 1995. Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii. Infect. Immun. 63:1827-1834.
92. Holmes AR, McNab R, Jenkinson HF. 1996. Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesinreceptor interactions. Infect. Immun. 64:4680-4685.
93. Holst D. 2005. Causes and prevention of dental caries: a perspective on cases and incidence. Oral Health Prev. Dent. 3:9-14.
94. Hopkins MJ, Sharp R, Macfarlane GT. 2002. Variation in human intestinal microbiota with age. Dig. Liver Dis. 34(Suppl. 2):S12-S18.
95. Hu QG, Zheng QC. 2003. The influence of enteral nutrition in postoperative patients with poor liver function. World J. Gastroenterol. 9:843-846.
96. Hughes KA, Sutherland IW, Jones MV. 1998. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144(Pt. 11):3039-3047.
97. Jabra-Rizk MA, et al. 1999. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J. Clin. Microbiol. 37:1464-1468.
98. Jacques I, Derelle J, Weber M, Vidailhet M. 1998. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur. J. Pediatr. 157:427-431.
99. James GA, et al. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37-44.
100. Janssen PH. 1992. Growth yield increase and ATP formation linked to succinate decarboxylation in Veillonella parvula. Arch. Microbiol. 157: 442-445.
101. Jayatilake JA, Samaranayake YH, Samaranayake LP. 2008. A comparative study of candidal invasion in rabbit tongue mucosal explants and reconstituted human oral epithelium. Mycopathologia 165:373-380.
102. Jenkinson HF, Lala HC, Shepherd MG. 1990. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect. Immun. 58:1429-1436.
103. Jiang Z, et al. 1999. Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect. Immun. 67:187-192.
104. Kerr JR, et al. 1999. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52:385-387.
105. Kesavalu L, et al. 2007. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75: 1704-1712.
106. Klein JO. 2000. The burden of otitis media. Vaccine 19(Suppl. 1):S2-S8.
107. Klinke T, et al. 2009. Acid production by oral strains of Candida albicans and lactobacilli. Caries Res. 43:83-91.
108. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. 1985. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4:110-125.
109. Kolenbrander PE, Andersen RN, Moore LV. 1990. Intrageneric coaggregation among strains of human oral bacteria: potential role in primary colonization of the tooth surface. Appl. Environ. Microbiol. 56: 3890-3894.
110. Kolenbrander PE, Ganeshkumar N, Cassels FJ, Hughes CV. 1993. Coaggregation: specific adherence among human oral plaque bacteria. FASEB J. 7:406-413.
111. Krishnamurthy A, McGrath J, Cripps AW, Kyd JM. 2009. The incidence of Streptococcus pneumoniae otitis media is affected by the polymicrobial environment particularly Moraxella catarrhalis in a mouse nasal colonisation model. Microbes Infect. 11:545-553.
112. Kuramitsu HK, He X, Lux R, Anderson MH, Shi W. 2007. Interspecies interactions within oral microbial communities. Microbiol. Mol. Biol. Rev. 71:653-670.
113. Lafaurie GI, et al. 2007. Demographic, clinical, and microbial aspects of chronic and aggressive periodontitis in Colombia: a multicenter study. J. Periodontol. 78:629-639.
114. Larsen MK, Thomsen TR, Moser C, Hoiby N, Nielsen PH. 2008. Use of cultivation-dependent and-independent techniques to assess contamination of central venous catheters: a pilot study.BMCClin. Pathol. 8:10.
115. Laufer AS, et al. 2011. Microbial communities of the upper respiratory tract and otitis media in children. mBio 2(1):e00245-10. doi:10.1128/ mBio.00245-10.
116. Lepp PW, et al. 2004. Methanogenic Archaea and human periodontal disease. Proc. Natl. Acad. Sci. U. S. A. 101:6176-6181.
117. Li CL, et al. 2009. Prevalence and molecular diversity of Archaea in subgingival pockets of periodontitis patients. Oral Microbiol. Immunol. 24:343-346.
118. Li J, et al. 1995. Effects of parenteral and enteral nutrition on gutassociated lymphoid tissue. J. Trauma 39:44-52.
119. Li Y, Ge Y, Saxena D, Caufield PW. 2007. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J. Clin. Microbiol. 45:81-87.
120. Li Y, Ku CY, Xu J, Saxena D, Caufield PW. 2005. Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J. Dent. Res. 84:559-564.
121. Lim DJ, et al. 2000. Cell biology of tubotympanum in relation to pathogenesis of otitis media-a review. Vaccine 19(Suppl. 1):S17-S25.
122. Lin J, Lee IS, Frey J, Slonczewski JL, Foster JW. 1995. Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli. J. Bacteriol. 177:4097-4104.
123. Liou TG, et al. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol. 153:345-352.
124. Lu TK, Collins JJ. 2009. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc. Natl. Acad. Sci. U. S. A. 106:4629-4634.
125. MacFie J, et al. 1999. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45:223-228.
126. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R. 1992. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J. Antimicrob. Chemother. 30:615-623.
127. Manson JM, Rauch M, Gilmore MS. 2008. The commensal microbiology of the gastrointestinal tract. Adv. Exp. Med. Biol. 635:15-28.
128. Margolin L, Gialanella P. 2010. Assessment of the antimicrobial properties of maggots. Int. Wound J. 7:202-204.
129. Margolis HC, Moreno EC. 1994. Composition and cariogenic potential of dental plaque fluid. Crit. Rev. Oral Biol. Med. 5:1-25.
130. Marshall JC, Christou NV, Meakins JL. 1993. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann. Surg. 218: 111-119.
131. Maruyama K, et al. 2007. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am. J. Pathol. 170:1178-1191.
132. Mastropaolo MD, et al. 2005. Synergy in polymicrobial infections in a mouse model of type 2 diabetes. Infect. Immun. 73:6055-6063.
133. McAlester G, O'Gara F, Morrissey JP. 2008. Signal-mediated interac-tions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 57:563-569.
134. McGillivary G, Mason KM, Jurcisek JA, Peeples ME, Bakaletz LO. 2009. Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cell. Microbiol. 11:1399-1408.
135. McKenney D, Brown KE, Allison DG. 1995. Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J. Bacteriol. 177: 6989-6992.
136. McPherson MA, Shori DK, Dormer RL. 1988. Defective regulation of apical membrane chloride transport and exocytosis in cystic fibrosis. Biosci. Rep. 8:27-33.
137. McVay CS, Velasquez M, Fralick JA. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51:1934-1938.
138. Mehall JR, et al. 2002. Prospective study of the incidence and complications of bacterial contamination of enteral feeding in neonates. J. Pediatr. Surg. 37:1177-1182.
139. Minah GE, Loesche WJ. 1977. Sucrose metabolism by prominent members of the flora isolated from cariogenic and non-cariogenic dental plaques. Infect. Immun. 17:55-61.
140. Mombelli A, Casagni F, Madianos PN. 2002. Can presence or absence of periodontal pathogens distinguish between subjects with chronic and aggressive periodontitis? A systematic review. J. Clin. Periodontol. 29(Suppl. 3):10-21; discussion 37-38.
141. Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. 1993. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 103:805-811.
142. Mumcuoglu KY, et al. 1999. Maggot therapy for the treatment of intractable wounds. Int. J. Dermatol. 38:623-627.
143. Murphy TF, Bakaletz LO, Smeesters PR. 2009. Microbial interactions in the respiratory tract. Pediatr. Infect. Dis. J. 28:S121-S126.
144. Muthig M, Hebestreit A, Ziegler U, Seidler M, Muller FM. 2010. Persistence of Candida species in the respiratory tract of cystic fibrosis patients. Med. Mycol. 48:56-63.
145. Nascimento-Carvalho CM. 2009. Pneumococcal conjugate vaccination and otitis media: differences among high-risk and low-risk populations. Expert Rev. Vaccines 8:695-698.
146. Niederman R, Buyle-Bodin Y, Lu BY, Robinson P, Naleway C. 1997. Short-chain carboxylic acid concentration in human gingival crevicular fluid. J. Dent. Res. 76:575-579.
147. Nishioka GJ, Jones JK, Triplett RG, Aufdemorte TB. 1988. The role of bacterial-laden biofilms in infections of maxillofacial biomaterials. J. Oral Maxillofac. Surg. 46:19-25.
148. Nobbs AH, Vickerman MM, Jenkinson HF. 2010. Heterologous expression of Candida albicans cell wall-associated adhesins in Saccharomyces cerevisiae reveals differential specificities in adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot. Cell 9:1622-1634.
149. Nord CE, Kager L. 1984. The normal flora of the gastrointestinal tract. Neth. J. Med. 27:249-252.
150. O'Brien KL, et al. 2007. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis. 196:1211-1220.
151. O'Connor J, Kells A, Henry S, Scalea T. 2005. Vacuum-assisted closure for the treatment of complex chest wounds. Ann. Thorac. Surg. 79: 1196-1200.
152. Ohlsen K, et al. 2003. Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environ. Microbiol. 5:711-716.
153. Oliver BG, et al. 2008. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63: 519-525.
154. O'May GA, Reynolds N, Macfarlane GT. 2005. Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients. Appl. Environ. Microbiol. 71:4777-4783.
155. O'May GA, Reynolds N, Smith AR, Kennedy A, Macfarlane GT. 2005. Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding. J. Clin. Microbiol. 43:3059-3065.
156. O'Sullivan JM, Jenkinson HF, Cannon RD. 2000. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 146(Pt. 1): 41-48.
157. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087.
158. Paradiso PR. 2011. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Clin. Infect. Dis. 52:1241-1247.
159. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
160. Paster BJ, et al. 2001. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183:3770-3783.
161. Patel JA, Nair S, Revai K, Grady J, Chonmaitree T. 2009. Nasopharyngeal acute phase cytokines in viral upper respiratory infection: impact on acute otitis media in children. Pediatr. Infect. Dis. J. 28:1002-1007.
162. Paul AG, et al. 2009. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int. Wound J. 6:39-46.
163. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 8:340-349.
164. Peters BM, et al. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59:493-503.
165. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. 2005. The global burden of oral diseases and risks to oral health. Bull. World Health Organ. 83:661-669.
166. Petersen PE, Ogawa H. 2005. Strengthening the prevention of periodontal disease: the WHO approach. J. Periodontol. 76:2187-2193.
167. Pizzorno R, et al. 1997. Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients. J. Urol. 158:837-840.
168. Pletz MW, Maus U, Krug N, Welte T, Lode H. 2008. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int. J. Antimicrob. Agents 32:199-206.
169. Prete PE. 1997. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 60:505-510.
170. Preza D, et al. 2008. Bacterial profiles of root caries in elderly patients. J. Clin. Microbiol. 46:2015-2021.
171. Pulimood S, Ganesan L, Alangaden G, Chandrasekar P. 2002. Polymicrobial candidemia. Diagn. Microbiol. Infect. Dis. 44:353-357.
172. Rani SA, et al. 2007. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J. Bacteriol. 189:4223-4233.
173. Rathur HM, Boulton AJ. 2007. The diabetic foot. Clin. Dermatol. 25: 109-120.
174. Resch A, Fehrenbacher B, Eisele K, Schaller M, Gotz F. 2005. Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol. Lett. 252:89-96.
175. Reuter G. 2001. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intest. Microbiol. 2:43-53.
176. Richard ML, Nobile CJ, Bruno VM, Mitchell AP. 2005. Candida albicans biofilm-defective mutants. Eukaryot. Cell 4:1493-1502.
177. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. 2003. Bacterial coaggregation: an integral process in the development of multispecies biofilms. Trends Microbiol. 11:94-100.
178. Riedel K, et al. 2001. N-Acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249-3262.
179. Roberts FJ. 1989. Definition of polymicrobial bacteremia. Rev. Infect. Dis. 11:1029-1030.
180. Rogers GB, Stressmann FA, Walker AW, Carroll MP, Bruce KD. 2010. Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Rev. Mol. Diagn. 10:187-196.
181. Rohacek M, et al. 2010. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 121:1691-1697.
182. Rollenhagen C, Sorensen M, Rizos K, Hurvitz R, Bumann D. 2004. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc. Natl. Acad. Sci. U. S. A. 101:8739-8744.
183. Sagel SD, et al. 2009. Impact of Pseudomonas and Staphylococcus infec-tion on inflammation and clinical status in young children with cystic fibrosis. J. Pediatr. 154:183-188.
184. Saini S, Mahajan A, Sharma JK, Arora Saini OP. 1999. Polymicrobial etiology of dental caries. Indian J. Pathol. Microbiol. 42:25-29.
185. Saito A, Inagaki S, Ishihara K. 2009. Differential ability of periodontopathic bacteria to modulate invasion of human gingival epithelial cells by Porphyromonas gingivalis. Microb. Pathog. 47:329-333.
186. Saito A, et al. 2008. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol. Med. Microbiol. 54:349-355.
187. Saito Y, et al. 2008. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis. Oral Microbiol. Immunol. 23: 1-6.
188. Sanford BA, Shelokov A, Ramsay MA. 1978. Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection. J. Infect. Dis. 137:176-181.
189. Sawal M, et al. 2009. Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr. Pulmonol. 44:970-980.
190. Schaudinn C, Gorur A, Keller D, Sedghizadeh PP, Costerton JW. 2009. Periodontitis: an archetypical biofilm disease. J. Am. Dent. Assoc. 140: 978-986.
191. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. 2009. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 17:354-359.
192. Segal N, Leibovitz E, Dagan R, Leiberman A. 2005. Acute otitis media- diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int. J. Pediatr. Otorhinolaryngol. 69:1311-1319.
193. Sibley CD, et al. 2008. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog. 4:e1000184.
194. Sibley CD, et al. 2010. McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients. J. Med. Microbiol. 59:534-540.
195. Sibley CD, Rabin H, Surette MG. 2006. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol. 1:53-61.
196. Sibley CD, et al. 2010. The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J. Clin. Microbiol. 48:2592-2594.
197. Sillankorva S, Neubauer P, Azeredo J. 2010. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling 26:567-575.
198. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. 2010. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixedspecies communities. Infect. Immun. 78:4644-4652.
199. Stecher B, Hardt WD. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
200. Steed H, et al. 2010. The microbiological and immunological effects of synbiotic consumption-a randomized double-blind placebocontrolled study in active Crohn's disease. Aliment. Pharmacol. Ther. 32:872-883.
201. Stewart PS. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:107-113.
202. Stojadinovic O, et al. 2005. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167:59-69.
203. Stroud M, Duncan H, Nightingale J. 2003. Guidelines for enteral feeding in adult hospital patients. Gut 52(Suppl. 7):vii1-vii12.
204. Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD. 2008. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen. 16:805-813.
205. Tarsia P, Aliberti S, Pappalettera M, Blasi F. 2007. Mixed communityacquired lower respiratory tract infections. Curr. Infect. Dis. Rep. 9:14-20.
206. Tomlin KL, Coll OP, Ceri H. 2001. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can. J. Microbiol. 47:949-954.
207. Tunney MM, et al. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177:995-1001.
208. Tunney MM, et al. 2011. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 66:579-584.
209. Tuomanen E. 1986. Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infect. Immun. 54:905-908.
210. Urzua B, et al. 2008. Yeast diversity in the oral microbiota of subjects with periodontitis: Candida albicans and Candida dubliniensis colonize the periodontal pockets. Med. Mycol. 46:783-793.
211. Van Ewijk BE, et al. 2007. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr. Res. 61: 398-403.
212. Verghese A, Prabhu K, Diamond RD, Sugar A. 1988. Synchronous bacterial and fungal septicemia. A marker for the critically ill surgical patient. Am. Surg. 54:276-283.
213. Viale P, Stefani S. 2006. Vascular catheter-associated infections: a microbiological and therapeutic update. J. Chemother. 18:235-249.
214. Vuong C, et al. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-275.
215. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P. 1995. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect. Immun. 63:1153-1157.
216. Waite RD, et al. 2006. Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles. BMC Genomics 7:162.
217. Walters MC, III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323.
218. Warshauer D, Goldstein E, Akers T, Lippert W, Kim M. 1977. Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages. Am. Rev. Respir. Dis. 115:269-277.
219. Wat D, et al. 2008. The role of respiratory viruses in cystic fibrosis. J. Cyst. Fibros. 7:320-328.
220. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. 1998. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust. Dent. J. 43:45-50.
221. Williams C. 2001. Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract. Res. Clin. Gastroenterol. 15: 511-521.
222. Williams RL. 1997. Hyperbaric oxygen therapy and the diabetic foot. J. Am. Podiatr. Med. Assoc. 87:279-292.
223. Wu SC, Driver VR, Wrobel JS, Armstrong DG. 2007. Foot ulcers in the diabetic patient, prevention and treatment. Vasc. Health Risk Manag. 3:65-76.
224. Yeh SH, et al. 2010. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics 126: e493-505.
225. Yilmaz O. 2008. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology 154: 2897-2903.
226. Zhang T, Hashizume T, Kurita-Ochiai T, Yamamoto M. 2009. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity. Biochem. Biophys. Res. Commun. 390:937-941.
227. Zheng Q, Hu Q. 2001. The influence of enteral nutrition on gut barrier in the post-operative patients with damaged hepatic function. J. Tongji Med. Univ. 21:323-325.